Functional duality of merlin: A conundrum of proteome complexity

Medical Hypotheses

Volumn 67, Issue 5, 2006, Pages 1095-1098

  Chen, Z ^a   Fadiel, A ^a,b   Xia, Y ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MERLIN; MOESIN; ONCOPROTEIN; PROTEOME; RADIXIN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL MOTILITY; CELL TYPE; DOWN REGULATION; HUMAN; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; MEMBRANE PROTEINS; NEOPLASM METASTASIS; NEOPLASMS; NEURILEMMOMA; NEUROFIBROMIN 2; OVARIAN NEOPLASMS; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEINS;

EID: 33748083387     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.063     Document Type: Article

References (23)

1. Trofatter J.A., MacCollin M.M., Rutter J.L., Murrell J.R., Duyao M.P., Parry D.M., et al. A novel moesin, ezrin, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72 (1993) 791-800
2. Rouleau G.A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., et al. Alteration in a new gene encoding a putative membrane organizing protein causes neuromatosis type 2. Nature 363 (1993) 515-521
3. Bianchi A.B., Hara T., Ramesh V., Gao J., Klein-Szanto A.J., Morin F., et al. Mutations in transcripts isoforms of the neurofibromatosis 2 gene in SCH gene in multi human tumor types. Nat Genet 6 (1994) 185-192
4. Bretscher A., Chambers D., Nguyen R., and Rezec D. ERM-merlin and EBP50 protein families in plasma membrane organization and function. Ann Rev Cell Biol 16 (2000) 113-143
5. Gautreau A., Louvard D., and Arpin M. ERM proteins and NF2 tumor suppressor: the yin and yang of cortical actin organization and cell growth signaling. Curr Opin Cell Biol 14 (2002) 104-109
6. Martin T.A., Harison G., Mansel R.E., and Jian W.G. The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46 (2003) 165-186
7. Bretcher A., Chambers D., Nguyen R., and Reczek D. ERM-merlin and EBP50 protein families in plasma membrane organization and function. Ann Rev Cell Dev Biol 16 (2000) 113-143
8. James M.F., Manchanda N., Gonzelez Agosti C., Hartwig J.H., and Ramesh V. The neurofibromatsis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association. Biochem J 356 (2001) 377-386
9. Shaw R.J., Paez J.G., Curto M., Yaktine A., Pruitt W.M., Saotome I., et al. The NF2 tumor suppressor, merlin, function in Rac-dependent signaling. Dev Cell 1 (2001) 63-72
10. Gronholm M., Sainio M., Zhao F., Heiska L., Vaheri A., and Carpen O. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin. J Cell Sci 112 (1999) 895-904
11. Nguyen R., Reczek D., and Bretscher A. Hierarchy of merlin and ezrin N-and C-terminal domain interactions in homo-and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3kARP. J Biol Chem 276 (2001) 7621-7629
12. Chen Z., Fadiel A., Sakamoto H., Otani K., Rutherford T., and Noftolin F. Overian cancer proliferation, ezrin translocation and tyrosine phosphorylation are stimulated by interleukin 1 and epidermal growth factor. Cancer 92 (2001) 3068-3075
13. Kaul S.C., Mitsui Y., Komatsu Y., Reddel R.R., and Wadhwa R. A highly expressed 81 kDa proteins in immortalized mouse fibroblasts: its proliferative function and identity with ezrin. Oncogene 13 (1996) 1231-1237
14. Brault E., Gautreau A., Lamarine M., Callebaut I., Thomas G., and Goutebonze L. Normal membrane localization and actin association of NF2 tumor suppressor protein are dependent on folding of its N-terminal domain. J Cell Sci 114 (2001) 1901-1912
15. Ohtani K., Sahamoto H., Rutherford T., Chen Z., Parkash V., Carcangui M.L., et al. Ezrin, a membrane cytoskeletal linking protein is involved in the process of invasion and metastasis of human endometrial cancer. Cancer Lett 147 (1999) 31-38
16. Elliott B.E., Meens J.A., SenGupta S.K., Louvard D., and Arpin M. The membrane crosslinker ezrin is required for metastasis of breast cancer cells. Breast Cancer Res 2 (2005) R365-R373
17. Xiao G.H., Gallagher R., Shetler J., Skele K., Altomare D.A., Pestell R.G., et al. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation by repressing cyclin D1 repression. Mol Cell Biol 25 (2005) 2384-2394
18. Giovannini M., Robanus-Maandag E., Niwa-Kawakita M., van der Valk M., Woodruff J.M., Goutebroze L., et al. Schwanoma cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13 (1999) 978-986
19. Westfall M.D., and Pietenpol J.A. P63: molecular complexity in development and cancer. Carcinogenesis 24 (2004) 857-864
20. Eferl R., and Wagner E.F. AP-1: a double edged sword in tumorigenesis. Nature Rev Cancer 3 (2003) 859-868
21. Ma M.C., Qian H., Ghassemi F., Zhao P., and Xia Y. Oxygen-sensitive delta-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 280 (2005) 16208-16218
22. Zhang J., Qian H., Zhao P., Hong S.S., and Xia Y. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke 37 (2006) 1094-1099
23. Ammon-Treiber S., Stolze D., Schroder H., Loh H., and Hollt V. Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 49 (2005) 1160-1169